In vitro studies of adiponectin on several colon cancer cell lines (HCT116, HT29, and LoVo) show that adiponectin inhibits colon cancer cell proliferation and impairs the cell cycle at G1/S transition phase by inducing p21 and p27 [134]. Here, ADIPOQ is linked to malignant colon neoplasm.